Late-occurring venous thromboembolism in allogeneic blood or marrow transplant survivors: a BMTSS-HiGHS2 risk model

Allogeneic blood or marrow transplant (BMT) recipients are at risk for venous thromboembolism (VTE) because of high-intensity therapeutic exposures, comorbidities, and a proinflammatory state due to chronic graft-versus-host disease (GVHD). The long-term risk of VTE in allogeneic BMT survivors remai...

Descripción completa

Detalles Bibliográficos
Autores principales: Gangaraju, Radhika, Chen, Yanjun, Hageman, Lindsey, Wu, Jessica, Francisco, Liton, Kung, Michelle, Weisdorf, Daniel J., Forman, Stephen J., Arora, Mukta, Armenian, Saro H., Bhatia, Smita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2021
Materias:
Thrombosis and Hemostasis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945641/
https://www.ncbi.nlm.nih.gov/pubmed/34461633
http://dx.doi.org/10.1182/bloodadvances.2021004341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945641/
https://www.ncbi.nlm.nih.gov/pubmed/34461633
http://dx.doi.org/10.1182/bloodadvances.2021004341

Ejemplares similares